ABSTRACT
The bugbear of interventional cardiology, restenosis is a recurring problem which affects every cardiologist, whether consultant or resident/registrar, and entails further intervention, whether it be angioplasty, stenting or therapeutic. The economic costs of reintervention and the distress caused to the patient have meant that clinical trials have
TABLE OF CONTENTS
part |2 pages
References
